We have recently observed that protein kinase C (PKC) was involved in the regulation of the accumulation of mRNAs of the AP-1 components in cultured Abelsontransformed murine fetal-liver-derived mast cells stimulated by exocytotic stimuli. Here we analyzed the probable regulatory effect of PKC on the synthesis and DNA-binding activity of AP-1 complexes in immunologic stimulated mast cells. In this study we used the interleukin-3-dependent murine fetal-liver-derived mast cells that were not transformed by the Abelson oncogene. Study of PKC-depleted cells showed PKC dependency of c-fos mRNA accumulation and protein expression in IgE-Ag stimulated cells. In contrast, the c-jun mRNA accumulation was unaffected by PKC depletion, whereas its protein expression was dependent on this enzymatic activity. This suggests the involvement of PKC in the regulation of translation of c-Jun, a level of c J u n regulation that was not previously described. The amount of AP-1 DNA-bound complex was AST CELLS PLAY a critical role in the pathogenesis
We have recently observed that protein kinase C (PKC) was involved in the regulation of the accumulation of mRNAs of the AP-1 components in cultured Abelsontransformed murine fetal-liver-derived mast cells stimulated by exocytotic stimuli. Here we analyzed the probable regulatory effect of PKC on the synthesis and DNA-binding activity of AP-1 complexes in immunologic stimulated mast cells. In this study we used the interleukin-3-dependent murine fetal-liver-derived mast cells that were not transformed by the Abelson oncogene. Study of PKC-depleted cells showed PKC dependency of c-fos mRNA accumulation and protein expression in IgE-Ag stimulated cells. In contrast, the c-jun mRNA accumulation was unaffected by PKC depletion, whereas its protein expression was dependent on this enzymatic activity. This suggests the involvement of PKC in the regulation of translation of c-Jun, a level of c J u n regulation that was not previously described. The amount of AP-1 DNA-bound complex was AST CELLS PLAY a critical role in the pathogenesis M of disorders of IgE-dependent immediate hypersensitivity. The immunologic activation secretion response of these cells through the activation of their surface-IgE Fc receptor is associated with the synthesis and release of their contents, ie, a variety of cytokines, lipid-derived mediators, amines, serine proteases, and proteoglycans.' This activation of mast cells by IgE-Ag also modulates their DNA synthesis." Currently, most of the biochemical basis of signal transduction across the cell membrane that leads to such phenomena is unknown, An indication of the signal transduction associated with mast cell DNA synthesis came from our observation that an increase in protein kinase C (PKC) activity was associated with a decrease in mast cell DNA synthesis that occurred within a few hours after IgE-Ag acti~a t i o n .~ One of the ways by which such a stimulus could affect mast cell growth is by modulating the transcription of responding genes. The most studied transcription factor that seems to be important for the entry of cells into S phase is AP-I, a heterodimeric complex of either Juns or Fos and J u a 6 Fos protein cannot homodimerize, but forms a highly stable complex via the leucine-zipper interaction with the Jun proteins.'** As a heterodimer, Fos and Jun activate transcription through the AP-1 binding site.','' The regulation of AP-1 activity can be controlled at several levels: mRNA transcription and stability, degradation of its components,"*'2 or at the level of DNA binding activity. Furthermore, it was shown that the stability of c-Fos was increased when the protein was dimerized with c-Jun dephosphorylated as a result of PKC activity.I3 Another point of regulation of AP-1 activity is the dimerization of its components to other proteins. Recently, a Fos interacting protein (FIP) was characterized and its sequence contains both the consensus for the basic-helix loop-helix and the leucine-zipper domains. l 4 We observed that PKC activity is involved in mRNA accumulation of the proto-oncogene c-fos and jun family in also lowered in PKC-depleted cells. Therefore, PKC plays an important regulatory role in different stages of the signal transduction pathway because of IgE-Ag stimulation. Surprisingly, we have observed that although the amount of total synthesized c-Fos began to increase 15 minutes after immunologic stimulation, the amount of c-Fos associated with Juns did not increase, even after 45 minutes. This association was not affected by PKC. Using a Fos-interacting protein (FIP)-cDNA probe, an expression of 2.9 kb mRNA was detected in these cells. Furthermore, immunologic stimulation caused an increase in the amount of a Fos-containing protein complex that bound to an FIP-binding DNA oligonucleotide. Therefore, we propose that this protein complex that contains most of the immunologically induced c-Fos has an important role in IgE-Ag-stimulated signal transduction. Abelson-MuLV-transformed mast cells that were stimulated by IgE-Ag.I5 However, data regarding IgE-Ag-induced translation of AP-1 components in untransformed mast cells, its binding activity, as well as PKC's involvement in these processes, are poorly documented. Thus, to further investigate the regulation of AP-1 activity in IgE-Ag-stimulated mast cells, we initiated the present study on interleukin-3 (IL-3)-dependent murine fetal-liver-derived mast cells (MC-9). Here we show that PKC plays an important role in the regulation of translation of c-Jun rather than on its mRNA accumulation. Also, this enzyme participates in the regulation of AP-I binding activity. Surprisingly, only a negligible amount of the immunologically induced c-Fos was detected in the AP-1 complexes. An expression FIP mRNA was detected in these cells. Therefore, we performed gel retardation and c-Fos supershift assays with an FIPbinding oligonucleotide. The results from these experiments strongly suggest that most of the newly synthesized c-Fos form a heterodimer with FIP or a closely related protein.
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MATERIALS AND METHODS
Cell culture. MC-9 cells16 were obtained from the American Type Culture Collection (Rockville, MD). The cells were maintained in RPMI-1640 supplemented with 2 mmol/L L-glutamine, 2 mmol/L nonessential amino acids, 100 U/mL penicillin, 100 pg/ mL streptomycin (GIBCO, Grand Island, NY), 50 mmol/L &mer-captoethanol (Fisher Scientific, Medford, MA), 10% fetal calf serum (FCS; Bio-Lab, Jerusalem, Israel), and 20% WEHI-3 conditioned medium."
Chronic treatment with phorbol myristate acetate (PMA). Mast cells were incubated for 72 hours at 37°C in the presence or absence of 20 ng PMA/mL (Sigma Chemical Co, St Louis, MO).
Preparation of cytosolic and particulate membrane fractions. Five million MC-9 cells grown in enriched medium containing 20% WEHI-3 conditioned medium were treated with 20 ng/mL of PMA for 72 hours before processing. Cells were removed into ice and then washed once by centrifugation at 500g in 4 mL of cold serum-free RPMI-1640 containing 1 mmol/L sucrose. The sucrose was added to the medium to pellet the viable cells at the end of each treatment." The supernatant of each sample was removed, and the cells in the pellet were lysed in 50 pL of ice-cold double-distilled water, by two cycles of freezing and thawing in liquid nitrogen, and immediately reconstituted with 450 p L of ice-cold extraction buffer (20 mmol/L Tris-HC1, 50 pmol/L 0-mercaptoethanol, 100 pg/mL aprotonin) (Sigma). Cytosol fractions were prepared by centrifugation at 80,OOOg for 60 minutes at 4°C. The supernatants were collected for determination of cytosolic PKC activity. Membrane pellets were homogenized by 70 up-and-down strokes on ice in the course of 60 minutes with tight-fitting homogenizers in 500 pL of ice-cold homogenization buffer (extraction buffer + 0.1 % Triton; Sigma), followed by centrifugation at 80,OOOg for 60 minutes. After checking the PKC activity in the original Triton-treated particulate fraction, we found that the collected supernatant contained all the PKC activity associated with the membrane fraction.
PKC activity in the membrane fractions was then determined. One hundred percent cell lysis was confirmed by testing release of lactate dehydrogenase into the supernatants.
Cell-free PKC assay. PKC activity was determined essentially as previously de~cribed.'~ Reaction mixtures contained 10 mmol/L MgCI,, I mmol/L CaCI,, 100 pg histone (type 1 1 1-S), with or without 20 pg of phosphatidylserine and 5 pg of 1,2-diacylglycerol (DAG) (Sigma), and 10 pmol/L [3zP]-adenosine triphosphate (Amershsam Corp, Arlington Heights, IL) in a final volume of 250 pL of 20 mmol/L Tris-HCI. Before addition to the reaction mixtures, phosphatidylserine and DAG were prepared by evaporation under N2 and sonication in 20 mmol/L Tris-HCI pH 7.5. Enzyme reactions were started by the addition of 50 pL of either cytosol, or membrane fractions to the reaction mixtures, and the samples were incubated for 10 minutes at 30°C. Reactions were stopped by pipeting 100 pL from each sample onto a square (2.5 X 2.5 cm) filter paper (Whatman 3M chr; Whatman, Maidstone, UK) that was then immediately washed with agitation in 200 mL of ice-cold 10% trichloroacetic acid for 10 minutes. This was followed by three 20-minute washes in 10% trichloroacetic acid at room temperature and a fourth wash overnight. The papers were then soaked in 95% ethanol for 5 minutes, soaked in ether for an additional 5 minutes, and then allowed to air dry before counting.
MC-9 cells were transferred to RPMI serum-free medium for a 2-hour incubation with or without a supplement of 20 ng PMA/mL. IgE sensitization was performed by incubating replicates of 2. 
IgE-Ag-mediated activation.
mmol/L Mg2+, and 1 mg/mL gelatin, in the presence or absence of PMA or IO-' mol/L H-7 (Sigma). The cells were then incubated at 37°C with 250 ng DNP coupled to bovine serum albumin (DNP-BSA) for defined periods of time. The reaction was stopped by centrifugation. Cell viability before and after each experiment was greater than 95%, as determined by trypan-blue exclusion.
Immunoprecipitation. After IgE sensitization, cells were washed once with 1 mL Dulbecco's modified Eagle's medium (DMEM)-Methionine free medium (Biological Industry, Beth Haemek, Israel) and resuspend in 250 pL of DMEM-Methionine free medium containing 50 pCi [35S]-methionine (Amersham) supplemented with or without 20 ng PMA/mL or IO-' mol/L of H-7 (Sigma). The cells were then activated with DNP-BSA for 45 minutes as described above. The immunoprecipitation procedure that was previously described" was modified as follows: 2.5 million cells were lysed by the addition of 500 pL cold lysis buffer (0.01 mol/L Tris-HC1 pH 7.4, 1% deoxycholate, I % Triton X-100,O. 1% sodium dodecylsulfate [SDS], 0.15 mol/L NaCI, and 0.25 mmol/L phenylmethylsulfonyl fluoride). Cells were then homogenized and their supernatants were collected after a 30-minute centrifugation in a microcentrifuge at 4°C. Affinity-purified sheep anti-c-fos antibody that was either preincubated or not with c-Fos peptide (Cambridge Research Biochemicals, Wilmington, DE) was added to the supernatants. After overnight incubation at 4"C, rabbit-antisheep antiserum (Bio-Makor, Rehovot, Israel) was added and the mixtures were incubated for 2 hours at 4°C. Then, IO mg of protein-A Sepharose beads (Sigma) was added and the mixtures incubated with agitation for 3 hours at 4°C. The protein A-Sepharose beads were washed three times with lysis buffer and then washed once with Tris-EDTA washing buffer. A similar procedure was used to determine the c-Jun, using rabbit anti-c-Jun antibody (Oncogene Science Inc, NY). After being boiled in Laemmli sample buffer containing 0.5% SDS, precipitates were resolved on discontinuous 10% acrylamide-bisacrylamide SDS slab gels. The gels were dried and exposed to Kodak X-Omat AR film (Eastman-Kodak, Rochester, NY) at -70°C for different lengths of time. The same lysates were used for sequential immunoprecipitation for the determination of the AP-I-bound versus free Fos by using the following procedure:,' The immunocomplexes derived from the treatment ofthe lysates with Jun family antibody (kindly provided by Dr R. Bravo, Squib Co, NJ) were dissociated by boiling for 10 minutes in the presence of 0.5% SDS and then diluted fivefold with non-SDS buffer. The samples were reprecipitated with c-Fos antibody. Quantitation of the autoradiographic bands was performed by densitometric analysis.
Isolation of cytosolic RNA. Ten million cells per treatment were pelleted and lysed in lysis buffer containing heparin, spermidine, and NP-40 (Sigma); centrifuged immediately to remove the nuclei; and processed by phenol and chloroform:isoamylalcohol extraction." The RNA was precipitated overnight at -20°C in ethanol and sodium chloride, then washed in 70% ethanol and the concentration determined in a spectrophotometer.
For Northern blot-analysis samples of 10 pg RNA derived from MC-9 cells were concentrated and denatured in a mixture of formaldehyde (BDH, UK) and formamide (Fluka, Buchs, Switzerland) for 10 minutes at 65OC.'' The samples were separated on an agarose-MOPS gel (Sigma). The gel was blotted onto a Hybond-N filter (Amersham) and then the filter was exposed to UV for 4 minutes. Hybridization was performed at 42°C for 24 hours in a solution containing 6X SSC, 50% formamide, 1% SDS, 5 X Denhardt's solution, 10 mmol/L EDTA, 50 mmol/L Tris (pH 8), and 20 ng of heat-denatured [32P]-labeled DNA probes. After washing once in 2X SSC, 0.1% SDS at room temperature and once for 25 minutes at 56"C, the papers were
Northern blot analysis.
For personal use only. on October 30, 2017. by guest www.bloodjournal.org (Fig I A, lanes I and 3;  Fig I B, lanes I and 2) . To evaluate the role played by PKC in the mRNA accumulation of these two proto-oncogenes, the cells were treated for 72 hours with 20 ng/mL of PMA. Total inhibition of PKC activity was observed both in the cytosol and in the particulate fraction of the cells (data not shown). The depletion of PKC did not significantly affect the level of c-jun mRNA (Fig IA, lanes 3 and 4) observed after the trigger, whereas a partial decrease in c:fos mRNA accumulation was observed (Fig 1 B, lanes 2 and 4) .
The involvement of PKC in the translational level. The c-Fos and c-Jun proteins were identified by using a reimmunoprecipitation technique?' with polyclonal antibodies against c-Fos and c-Jim. This technique facilitates the identification of the appropriate protein by eliminating most of the background. We were able to reconfirm the identifica- exposed at -70°C to film (Kodak Curix RP2) for up to 2 days. The relative intensities of the bands on the autoradiograms were quantified by a light-scanning densitometer.
ThecDNA probes. A c:/o.s-specific probe was used fortheanalysis of its specific mRNA level on Northern blots. A 3.2-kb EcoRIBumHI fragment was isolated from lambda c+os (mouse)-2 clone.22 The c-jrtn probe was a 400-bp oligonucleotide fragment derived from the 3' region of the mouse c-jttn gene generated by the polymerase chain reaction method. The primers were (5' primer) 5'-ATG CCC TCA ACG CCT CGT TCC TCC ACT-3' = residue 95 I, and (3' primer) 5'-CTG CTA CTG AGG CCA CCG CGG GAG CCA-3' = residue 1370. This probe was hybridized to a specific mRNA at a size of 2.6 kb. The FIP cDNA probe was isolated from the EcoRl site ofpBAT9 (kindly provided by Dr Blanar, University ofcalifornia at San Francisco). A 0.97-kb fragment bearing the rpL32 processed gene, 4A, joined to the 5' and 3' flanks of p3A was used as a control for loading of equivalent total RNA?'
The DNA fragments were labeled with [3zP]dCTP (Amersham) using the random primed-labeling techniquez4 up to a specific activity of 3 X IOs cpmlpg. Labeled probes were used at a final concentration of 5 X IO6 cpm/mL hybridization mixture.
Gel shifi assu~.~' Nuclear extracts were prepared from IO' cells and used in the gel shift assay as previously described.2' Synthetic double-stranded TRE, KB, and bHLH binding site oligonucleotides were used for this assay. The following sequences were synthesized: TRE-5'-AGCTTAAAAAAGCATGAGTCAGACACCTG-3', KB-5'-GGGACTTTCC-3' and bHLH binding site-S'GATCCTAGG-CCACGTGACCGG-3'. The nature of the bound proteins were identified by using rabbit polyclonal antibodies against c-Jun (kindly provided by R Bravo) and rabbit polyclonal anti-c-Fos antibody (Medac, Hamburg, Germany).
anti-c-Fos with the nonradioactive-c-Fos peptide, before the addition of the antibody to the lysate (Fig 2) . It (Fig 3, A and B, lanes 1 and 2) .
Although there was a clear and consistent trend ofelevation in c-Fos and c-Jzin synthesis after activating the cells, quantitative determination of five separated experiments by densitometric analysis showed a wide range, 5-to 70-fold over control, of the elevation factor.
The role played by PKC in the regulation of the translation of these proto-oncogenes in IgE-DNP-stimulated MC-9 cells was then investigated. Long-term treatment of the cells with PMA caused partial decrease in the level of the enhancement ofc-Fos because ofthe immunological stimulus (n = 3), (Fig 3A, lanes 2 and 4) . However, no effect on the level of c-Fos in the activated cells was observed when PKCactivitywasinhibited by 10-5mol/LH-7,aPKCinhibito?' (data not shown).
Inhibition ['*SI Methionine-labeled IgE-sensitized MC-9 cells were exposed for 45 minutes to DNP-BSA. c-fos was identified by preincubating the antibody with (2) or without (1) the c-fos peptide before t h e addition of t h e antibody to the cell lysates. Immunoprecipitates were analyzed by SDS-polyacwlamide gel electrophoresis (SDS-PAGE). One representative experiment out of three is shown here.
significantly reduced the expression of c-Jun in IgE-Agstimulated cells (Fig 3B, lanes 2 and 4; Fig 4, lanes 2 and 4) .
Table I summarizes the above reported results.
The ratio between the AP-I components. The ratio between the total c-Fos synthesized in the cells, and that associated with the AP-I complexes caused by IgE-Ag stimulation, was next determined in a kinetic experiment (Fig 5) . The lysates from [3SS]-methionine labeled cells were first immunoprecipitated with antibodies against either c-Fos or Jzin family, the immunocomplexes were then dissociated and diluted, and the samples were reprecipitated with c-Fos antibody. Quantitation of the autoradiographic bands by densitometric analysis showed that regardless of the increase in c-Fos expression after the immunologic stimulus, the amount of c-Fos that is bound to Jun proteins remained constant, even 45 minutes after the trigger. Inhibition of the PKC activity by long-term treatment with PMA did not significantly change this ratio (data not shown).
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(+) and (-) indicate increases or no change, respectively, as compared with cells that were not activated by exocytotic stimuli.
AP-I DNA-binding activity. Because AP-1 DNA-binding activity could be another site for regulation by PKC, we have examined the possible modulation of this activity by PKC. This was performed in a gel shift assay using nuclear proteins derived from either PKC-depleted or undepleted cells. Figure 6 shows that the immunologic trigger caused a significant increase of the AP-I DNA binding activity up to fourfold. Long-term PMA treatment of the cells caused enhancement in such activity. However, immunologic activation ofthe PKC-depleted cells resulted in a profound inhibition of the AP-I DNA binding activity. The unexpected increases in the binding activity of AP-I in the presence of KB oligonucleotide was observed in several experiments.
Expression and activity ofFlP. Because we have shown that most of the newly synthesized c-Fos is not associated with AP-1 complex, we determined whether it interacted with other proteins. Therefore, the expression and activity of the recently characterized FIP, a nuclear protein that could interact with c-Fox were determined in MC-9 cells. A 2.9-kb mRNA was detected in the cells (Fig 7, lanes I and  2) . IgE-Ag activation of cells, whether or not they were longterm with PMA, did not significantly affect the level of FIP mRNA accumulation (Fig 7) . By usinggel shift experiments with an FIP-binding oligon~cleotide.'~ we further confirmed the existence of FIP (Fig 8) . This binding activity was increased after immunologic activation, and decreased in activated cells depleted of PKC activity. The supershift obtained when the nuclear extract was preincubated with anti-c-Fos antibody indicates that c-FOS is associated with the complex bound to this sequence. ["SI Methionine-labeled activated cells were lysed with RlPA and incubated with antibodies against either c- Fos (lanes 1 , 3 , and 5) or with antibodies against Jun family (lanes 2,4, and 6 ). The immunocomplexes were dissociated, reprecipitated with c-Fos antibody, and analyzed by SDS-PAGE. Molecular weight is indicated in thousands. One representative experiment out of three is shown here.
For shown that the addition of fetal calf serum (FCS) induces cqos mRNA expression in mast cells.26 This elevated expression produces a background against which no induction of c-fos by IgE-Ag can be seenF6 As to the physiologic relevance of the FCS ability to mask the IgE-Ag effect on cqos. it is interesting to note that whereas FCS increases mast cell proliferation rates, rat and mouse serum reduces it.27 Thus, FCS contains growth factors that are not found in rodent serum. It seems logical to assume that these factors act in a similar way to many growth factors and cause egos induction. To avoid this potential pitfall, the cells were preincubated for 2 hours without FCS before experiments were per- proteins. However, we could not exclude the possibility that each antibody detected some other related proteins in each family. As opposed to the Fos family proteins, which could be varied by their different molecular weights, the various Jun proteins express similar molecular weights?' Therefore, although the c-Fos was clearly identified in this study, the detection of c-Jun out of the various Juns expressed is still questionable. PKC differentially affected the mRNA level of AP-1 components in IgE-Ag-stimulated MC-9 cells. Whereas the For personal use only. on October 30, 2017. by guest www.bloodjournal.org From level ofjun mRNA was not dependent on PKC activity, the c-fos mRNA's level was decreased after this activity was inhibited by long-term treatment with PMA. However, the translation of c-Jun was found to be PKC dependent. These results may indicate a different regulation site by PKC on AP-1 component expression.
It should be emphasized that in contrast to what we described here in the IL-3-dependent MC-9 cells, in our previous study we showed that IgE-Ag can induce c-fos mRNA accumulation in Abelson-transformed fetal-liver-derived murine mast cells via a PKC-independent pathway, whereas the accumulation of the mRNA of cjun is completely dependent on PKC a~tivity.'~ Therefore, it could be assumed that the tyrosine kinase activity of v-ab1 may change the dependence of these mRNAs accumulation on PKC activity.
Protein kinase C was shown in this study to also be involved in the regulation of AP-I DNA-binding activity in IgE-Ag-stimulated cells. However, changes in the amount of AP-I components could not explain all of the results observed in this study. It was reported that PKC-dependent phosphatase activity is responsible for the dephosphorylation of the inhibitory site in the c-terminal of c-Jun that allows this protein to bind to DNA." This interpretation is not sufficient for evaluating our observation that an increase in AP-I DNA-binding activity was observed in quiescent cells treated long-term with PMA. It could be speculated that alternative phosphorylation pathways are enhanced in cells when PKC activity is shut off and then become responsible for phosphatase activation. These "salvage pathways" are then inhibited upon IgE-Ag stimulus of the cells. Further studies of the phosphorylation-dephosphorylation pattern of AP-I components are needed to understand the exact mechanisms responsible for the seemingly paradoxic induction of AP-I binding by PKC depletion in unstimulated cells and the slight enhancement of AP-1 binding activity as a result of NFKB competition.
Because c-Jun and c-Fos can bind to other proteins, we determined the relationship between these proteins within the AP-1 complexes after immunologic stimulation of the cells. Surprisingly, we found that the majority of the c-Fos synthesized in the cells after the immunologic stimulation was not associated with the AP-1 complex. Because c-Fos cannot bind independently to DNA, we further investigated a possible binding of c-Fos to other proteins. Blaner and Rutter14 recently described a Fos-heterodimerizing protein named FIP that possesses the ability to bind specifically to a short DNA sequence from the upper regulatory region of Adeno virus. Using an FIP cDNA probe, we detected a 2.9-kb mRNA in MC-9 cells. In addition, we showed that the amount of FIP binding sequence retarded by protein extracts from IgE-Ag-induced cells is much larger than that retarded by extracts from noninduced MC-9 cells. By using an antibody against c-Fos, we showed that this protein is included in these DNA binding complexes. Because FIP is a member of a protein family that also contains the USF 11,29 we cannot rule out the involvement of any member of this protein family, and perhaps a tissue-specific one in this DNA-binding complex. The ability of the different AP-I components to bind to an increasing number of other nuclear proteins can create elaborate patterns of transcription control that can be tissue or stimulus specific. Moreover, PKC activity can influence this transcription control by altering the abundance of specific components and the DNAbinding activity of the complex itself.
In the present work we showed induction of AP-1 components by IgE-Ag stimulation that is controlled by PKC in a specific manner. We also showed the binding of c-Fos to different DNA binding factors. These provide important clues for the elucidation of the mechanisms involved in IgEAg-mediated transcription factor activation in mast cells, and hopefully in other cells derived from the hematopoietic lineage.
